EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Inhibition of Retinal AdoRA2a Activity Attenuates Myopia Progression

Shengcong Liu, Zhenqi Guan, Xingxing Yang, Wenting Li, Wei Qu, Yixin Zhou, Fuxin Zhao, Qi Wang, Furong Huang, Wei Chen, Jia Qu, Xiangtian Zhou und 1 weitere

Investigative Ophthalmology & Visual Science · 2026

DOI: 10.1167/iovs.67.1.15 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Investigative Ophthalmology & Visual Science, 2026. Verfasst von Shengcong Liu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Eye Hospital, Wenzhou Medical University, Wenzhou, China. Hauptthemen laut MEDLINE: Receptor, Adenosine A2A, Retina, Myopia, Adenosine A2 Receptor Antagonists. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, Adenosine A2ARetinaMyopiaAdenosine A2 Receptor AntagonistsAnimalsMaleMice, Inbred C57BLMiceMice, KnockoutDisease ProgressionDisease Models, AnimalAdenosineReceptors, Dopamine D2ApyraseAntigens, CDBlotting, Western

Substanzen

Receptor, Adenosine A2AAdora2a protein, mouseAdenosineAdenosine A2 Receptor AntagonistsReceptors, Dopamine D2ApyraseCD39 antigenAntigens, CD

Autor:innen und Institutionen

  • Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Eye Hospital, Wenzhou Medical University, Wenzhou, China.
  • State Key Laboratory of Eye Health, Eye Hospital, Wenzhou Medical University, Wenzhou, China.
  • Research Unit of Myopia Basic Research and Clinical Prevention and Control, Chinese Academy of Medical Sciences (2019RU025), Wenzhou, Zhejiang, China.
  • Key Laboratory of Biomechanics and Mechanobiology (Beihang University), Ministry of Education; Key Laboratory of Innovation and Transformation of Advanced Medical Devices, Ministry of Industry and Information Technology…
  • Department of Ophthalmology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China; Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai, Pe…

Zitieren

APA

Liu, S., Guan, Z., Yang, X., Li, W., Qu, W., Zhou, Y., Zhao, F., Wang, Q., Huang, F., Chen, W., Qu, J., Zhou, X., & Pan, M. (2026). Inhibition of Retinal AdoRA2a Activity Attenuates Myopia Progression. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.67.1.15

Vancouver

Liu S, Guan Z, Yang X, Li W, Qu W, Zhou Y, et al. Inhibition of Retinal AdoRA2a Activity Attenuates Myopia Progression. Investigative Ophthalmology & Visual Science. 2026. doi:10.1167/iovs.67.1.15

BibTeX
@article{Liu2026,
  author = {Liu, Shengcong and Guan, Zhenqi and Yang, Xingxing and Li, Wenting and Qu, Wei and Zhou, Yixin and Zhao, Fuxin and Wang, Qi and Huang, Furong and Chen, Wei and Qu, Jia and Zhou, Xiangtian and Pan, Miaozhen},
  title = {Inhibition of Retinal AdoRA2a Activity Attenuates Myopia Progression},
  journal = {Investigative Ophthalmology & Visual Science},
  year = {2026},
  doi = {10.1167/iovs.67.1.15}
}
Kostenlos starten →